LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Tbet Deficiency Causes T Helper Cell Dependent Airways Eosinophilia and Mucus Hypersecretion in Response to Rhinovirus Infection.

    Nicholas Glanville / Tamlyn J Peel / Armin Schröder / Julia Aniscenko / Ross P Walton / Susetta Finotto / Sebastian L Johnston

    PLoS Pathogens, Vol 12, Iss 9, p e

    2016  Volume 1005913

    Abstract: Current understanding of adaptive immune, particularly T cell, responses to human rhinoviruses (RV) is limited. Memory T cells are thought to be of a primarily T helper 1 type, but both T helper 1 and T helper 2 memory cells have been described, and ... ...

    Abstract Current understanding of adaptive immune, particularly T cell, responses to human rhinoviruses (RV) is limited. Memory T cells are thought to be of a primarily T helper 1 type, but both T helper 1 and T helper 2 memory cells have been described, and heightened T helper 2/ lessened T helper 1 responses have been associated with increased RV-induced asthma exacerbation severity. We examined the contribution of T helper 1 cells to RV-induced airways inflammation using mice deficient in the transcription factor T-Box Expressed In T Cells (Tbet), a critical controller of T helper 1 cell differentiation. Using flow cytometry we showed that Tbet deficient mice lacked the T helper 1 response of wild type mice and instead developed mixed T helper 2/T helper 17 responses to RV infection, evidenced by increased numbers of GATA binding protein 3 (GATA-3) and RAR-related orphan receptor gamma t (RORγt), and interleukin-13 and interleukin-17A expressing CD4+ T cells in the lung. Forkhead box P3 (FOXP3) and interleukin-10 expressing T cell numbers were unaffected. Tbet deficient mice also displayed deficiencies in lung Natural Killer, Natural Killer T cell and γδT cell responses, and serum neutralising antibody responses. Tbet deficient mice exhibited pronounced airways eosinophilia and mucus production in response to RV infection that, by utilising a CD4+ cell depleting antibody, were found to be T helper cell dependent. RV induction of T helper 2 and T helper 17 responses may therefore have an important role in directly driving features of allergic airways disease such as eosinophilia and mucus hypersecretion during asthma exacerbations.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Subject code 570
    Language English
    Publishing date 2016-09-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

    Aran Singanayagam / Nicholas Glanville / Jason L. Girkin / Yee Man Ching / Andrea Marcellini / James D. Porter / Marie Toussaint / Ross P. Walton / Lydia J. Finney / Julia Aniscenko / Jie Zhu / Maria-Belen Trujillo-Torralbo / Maria Adelaide Calderazzo / Chris Grainge / Su-Ling Loo / Punnam Chander Veerati / Prabuddha S. Pathinayake / Kristy S. Nichol / Andrew T. Reid /
    Phillip L. James / Roberto Solari / Peter A. B. Wark / Darryl A. Knight / Miriam F. Moffatt / William O. Cookson / Michael R. Edwards / Patrick Mallia / Nathan W. Bartlett / Sebastian L. Johnston

    Nature Communications, Vol 9, Iss 1, Pp 1-

    2018  Volume 16

    Abstract: Corticosteroid therapy is frequently used for chronic obstructive pulmonary disease (COPD) but its use is associated with increased risk of pneumonia. Here the authors show that corticosteroid use impairs innate and adaptive immunity to rhinovirus ... ...

    Abstract Corticosteroid therapy is frequently used for chronic obstructive pulmonary disease (COPD) but its use is associated with increased risk of pneumonia. Here the authors show that corticosteroid use impairs innate and adaptive immunity to rhinovirus infection, which is restored by exogenous IFNβ.
    Keywords Science ; Q
    Language English
    Publishing date 2018-06-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

    Aran Singanayagam / Nicholas Glanville / Jason L. Girkin / Yee Man Ching / Andrea Marcellini / James D. Porter / Marie Toussaint / Ross P. Walton / Lydia J. Finney / Julia Aniscenko / Jie Zhu / Maria-Belen Trujillo-Torralbo / Maria Adelaide Calderazzo / Chris Grainge / Su-Ling Loo / Punnam Chander Veerati / Prabuddha S. Pathinayake / Kristy S. Nichol / Andrew T. Reid /
    Phillip L. James / Roberto Solari / Peter A. B. Wark / Darryl A. Knight / Miriam F. Moffatt / William O. Cookson / Michael R. Edwards / Patrick Mallia / Nathan W. Bartlett / Sebastian L. Johnston

    Nature Communications, Vol 9, Iss 1, Pp 1-

    2018  Volume 16

    Abstract: Corticosteroid therapy is frequently used for chronic obstructive pulmonary disease (COPD) but its use is associated with increased risk of pneumonia. Here the authors show that corticosteroid use impairs innate and adaptive immunity to rhinovirus ... ...

    Abstract Corticosteroid therapy is frequently used for chronic obstructive pulmonary disease (COPD) but its use is associated with increased risk of pneumonia. Here the authors show that corticosteroid use impairs innate and adaptive immunity to rhinovirus infection, which is restored by exogenous IFNβ.
    Keywords Science ; Q
    Language English
    Publishing date 2018-06-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.

    Nicholas Glanville / Gary R McLean / Bruno Guy / Valerie Lecouturier / Catherine Berry / Yves Girerd / Christophe Gregoire / Ross P Walton / Rebecca M Pearson / Tatiana Kebadze / Nicolas Burdin / Nathan W Bartlett / Jeffrey W Almond / Sebastian L Johnston

    PLoS Pathogens, Vol 9, Iss 9, p e

    2013  Volume 1003669

    Abstract: Human rhinovirus (RV) infections are the principle cause of common colds and precipitate asthma and COPD exacerbations. There is currently no RV vaccine, largely due to the existence of ∼150 strains. We aimed to define highly conserved areas of the RV ... ...

    Abstract Human rhinovirus (RV) infections are the principle cause of common colds and precipitate asthma and COPD exacerbations. There is currently no RV vaccine, largely due to the existence of ∼150 strains. We aimed to define highly conserved areas of the RV proteome and test their usefulness as candidate antigens for a broadly cross-reactive vaccine, using a mouse infection model. Regions of the VP0 (VP4+VP2) capsid protein were identified as having high homology across RVs. Immunization with a recombinant VP0 combined with a Th1 promoting adjuvant induced systemic, antigen specific, cross-serotype, cellular and humoral immune responses. Similar cross-reactive responses were observed in the lungs of immunized mice after infection with heterologous RV strains. Immunization enhanced the generation of heterosubtypic neutralizing antibodies and lung memory T cells, and caused more rapid virus clearance. Conserved domains of the RV capsid therefore induce cross-reactive immune responses and represent candidates for a subunit RV vaccine.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Subject code 570
    Language English
    Publishing date 2013-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.

    Stephanie Traub / Alexandra Nikonova / Alan Carruthers / Rebecca Dunmore / Katherine A Vousden / Leila Gogsadze / Weidong Hao / Qing Zhu / Katie Bernard / Jie Zhu / Michael Dymond / Gary R McLean / Ross P Walton / Nicholas Glanville / Alison Humbles / Musa Khaitov / Ted Wells / Roland Kolbeck / Andrew J Leishman /
    Matthew A Sleeman / Nathan W Bartlett / Sebastian L Johnston

    PLoS Pathogens, Vol 9, Iss 8, p e

    2013  Volume 1003520

    Abstract: Human rhinoviruses (HRV) cause the majority of common colds and acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). Effective therapies are urgently needed, but no licensed treatments or vaccines currently exist. Of the 100 ... ...

    Abstract Human rhinoviruses (HRV) cause the majority of common colds and acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). Effective therapies are urgently needed, but no licensed treatments or vaccines currently exist. Of the 100 identified serotypes, ∼90% bind domain 1 of human intercellular adhesion molecule-1 (ICAM-1) as their cellular receptor, making this an attractive target for development of therapies; however, ICAM-1 domain 1 is also required for host defence and regulation of cell trafficking, principally via its major ligand LFA-1. Using a mouse anti-human ICAM-1 antibody (14C11) that specifically binds domain 1 of human ICAM-1, we show that 14C11 administered topically or systemically prevented entry of two major groups of rhinoviruses, HRV16 and HRV14, and reduced cellular inflammation, pro-inflammatory cytokine induction and virus load in vivo. 14C11 also reduced cellular inflammation and Th2 cytokine/chemokine production in a model of major group HRV-induced asthma exacerbation. Interestingly, 14C11 did not prevent cell adhesion via human ICAM-1/LFA-1 interactions in vitro, suggesting the epitope targeted by 14C11 was specific for viral entry. Thus a human ICAM-1 domain-1-specific antibody can prevent major group HRV entry and induction of airway inflammation in vivo.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Subject code 572
    Language English
    Publishing date 2013-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top